Qiagen Licenses DNA Amplification Technology from Genetrix | GenomeWeb

NEW YORK (GenomeWeb News) – Spanish biotechnology holding company Genetrix today announced it has licensed its Qualiphi polymerase product to Qiagen.

The global, exclusive deal was reached through Genetrix's X-Pol subsidiary.

Qualiphi is a DNA polymerase licensed from the Spanish National Research Council and studies suggest that it may improve the amplifications of whole genomes and large stretches of DNA, Genetrix said.

Financial and other terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: Plasmodium knowlesi population structure, 'pre-adaptations' in algal ancestors of land plants, and more.

Replication studies that don't quite reflect the original findings underscore the need to better share data, the Wall Street Journal reports.

About two-thirds of proposals to work with select agents are denied — though most proposals that come in don't meet the definition of a restricted experiment, according to an analysis by the Centers for Disease Control and Prevention.

Researchers examine plant and human DNA found on the Shroud of Turin.